Neuraxpharm acquires Brain Therapeutics
Neuraxpharm Group (Neuraxpharm), a European specialty pharmaceutical company focused on the central nervous system (CNS), has expanded its business in Southeast Europe through the acquisition of Brain Therapeutics, a CNS-focused marketing and distribution company with expertise in the commercialisation of CNS products in Greece, Cyprus and the Balkan countries.